Summary Tyrian Diagnostics Limited (Tyrian Diagnostics) formerly Proteome Systems Limited is a medical equipment company that manufactures, and markets diagnostics for clinical and non-clinical applications. The company discovers and validates novel biomarkers for tuberculosis. It has developed a proprietary point of care diagnostics platform such as diagnostiQTM. Tyrian also develops various solutions for proteomics research. The company's technology comprises small disposable plastic capsule and a USB-driven reader machine. It distributes its product through partnerships with various marketing and distribution companies. Tyrian Diagnostics is headquartered in Sydney, New South Wales, Australia. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Tyrian Diagnostics Limited - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Tyrian Diagnostics Limited Company Snapshot 5 Tyrian Diagnostics Limited Company Overview 5 Tyrian Diagnostics Limited Pipeline Products and Clinical Trials Overview 6 Tyrian Diagnostics Limited - Pipeline Analysis Overview 8 Key Facts 8 Tyrian Diagnostics Limited - Major Products and Services 9 Tyrian Diagnostics Limited Pipeline Products by Development Stage 10 Tyrian Diagnostics Limited Pipeline Products Overview 12 Biomarker Test - Cystic Fibrosis 12 Biomarker Test - Cystic Fibrosis Product Overview 12 Prostate cancer diagnostic test using HCA 13 Prostate cancer diagnostic test using HCA Product Overview 13 Prostate Cancer Diagnostic Test using HCA 14 Prostate Cancer Diagnostic Test using HCA Product Overview 14 Second Generation TB POC Test 15 Second Generation TB POC Test Product Overview 15 Tyrian Diagnostics Limited - Key Competitors 16 Tyrian Diagnostics Limited - Key Employees 17 Tyrian Diagnostics Limited - Locations And Subsidiaries 18 Head Office 18 Recent Developments 19 Tyrian Diagnostics Limited, Recent Developments 19 Dec 19, 2011: Tyrian Signs Distribution Agreement For Tuberculosis Antibodies 19 Nov 24, 2011: Tyrian Diagnostics Announces Resignation Of Michael Vamos As CFO 19 Oct 15, 2009: Tyrian Seeks New Partner Opportunities For Tuberculosis Diagnostic Tests 19 Apr 30, 2009: Tyrian Announces Resignation Of Phillip Morley From Its Board 20 Nov 06, 2008: Proteome Systems Changes Its Name To Tyrian Diagnostics 20 Aug 29, 2008: Proteome Systems Reports Fiscal Year 2008 Results 20 Jul 16, 2008: Proteome Systems Reports Proof Of Concept Study Results For Prostate Cancer Diagnostic Program 20 Feb 29, 2008: Proteome Systems Reports 1H Fiscal 2008 Results 20 Jun 19, 2007: Proteome Systems Appoints New Directors 21 May 02, 2007: Proteome Systems Appoints New CEO 21 Appendix 22 Methodology 22 About GlobalData 22 Contact Us 22 Disclaimer 22
List of Tables
Tyrian Diagnostics Limited Pipeline Products and Clinical Trials Overview 6 Tyrian Diagnostics Limited Pipeline Products by Equipment Type 6 Tyrian Diagnostics Limited Pipeline Products by Indication 7 Tyrian Diagnostics Limited, Key Facts 8 Tyrian Diagnostics Limited, Major Products and Services 9 Tyrian Diagnostics Limited Number of Pipeline Products by Development Stage 10 Tyrian Diagnostics Limited Pipeline Products Summary by Development Stage 11 Biomarker Test - Cystic Fibrosis - Product Status 12 Biomarker Test - Cystic Fibrosis - Product Description 12 Prostate cancer diagnostic test using HCA - Product Status 13 Prostate cancer diagnostic test using HCA - Product Description 13 Prostate Cancer Diagnostic Test using HCA - Product Status 14 Prostate Cancer Diagnostic Test using HCA - Product Description 14 Second Generation TB POC Test - Product Status 15 Second Generation TB POC Test - Product Description 15 Tyrian Diagnostics Limited, Key Employees 17
List of Figures
Tyrian Diagnostics Limited Pipeline Products by Equipment Type 7 Tyrian Diagnostics Limited Pipeline Products by Development Stage 10
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certainRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.